See also this year's filing and all EDGAR filings for this company.
PDF Report 0001818794_2021_Dyne_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001818794, Dyne Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 349,087,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,946,000 |
| 3 | remainder_Assets | 2,301,000 |
| 4 | LiabilitiesCurrent | 10,967,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,447,000 |
| 9 | ResearchAndDevelopmentExpense | 45,200,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -790,000 |
| 13 | remainder_ComprehensiveNetIncome | -27,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 353,334,000 |
| 1 | Liabilities | 10,967,000 |
| 2 | Expenses | 58,647,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 342,367,000 |
| 5 | NetIncome | -59,437,000 |
| 6 | ComprehensiveNetIncome | -59,450,500 |
| 7 | BaseVar | 211,882,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.77 |
| 9 | EconomicCapitalRatio | 4.22 |
Edgar->Model Mapping
Feature Distribution
